Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 9/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.47 |
| ▸ | IDO1 | P14902 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.46 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.45 |
| ▸ | LAP3 | P28838 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4989088 | 1.00 | LTA4H (0.48) | LTA4HALDH1A1KMT2AALOX15BLM | |
| Hydrochloric Acid SCHEMBL7393352 | 0.98 | LTA4H (0.47) | LTA4HALDH1A1KMT2AALOX15BLM | |
| Hydrochloric Acid SCHEMBL9188911 | 0.98 | LTA4H (0.47) | LTA4HALDH1A1KMT2AALOX15BLM | |
| Trifluoroacetic Acid SCHEMBL28255326 | 0.92 | LTA4H (0.43) | LTA4HALDH1A1KMT2AALOX15BLM | |
| SCHEMBL561573 | 0.89 | LTA4H (0.56) | LTA4HALDH1A1KMT2AIDO1MAPK1 | |
| SCHEMBL28192478 | 0.89 | LTA4H (0.56) | LTA4HALDH1A1KMT2AIDO1MAPK1 | |
| SCHEMBL124387 | 0.89 | LTA4H (0.56) | LTA4HALDH1A1KMT2AIDO1MAPK1 | |
| SCHEMBL21232385 | 0.89 | LTA4H (0.56) | LTA4HALDH1A1KMT2AIDO1MAPK1 | |
| SCHEMBL6672089 | 0.88 | LTA4H (0.44) | LTA4HALDH1A1KMT2AALOX15BLM | |
| Hydrochloric Acid SCHEMBL15266392 | 0.87 | LTA4H (0.54) | LTA4HALDH1A1KMT2AIDO1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240065990-A1 | METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID | BELLUS HEALTH INC (CA) | 2024-02-29 | — | — | US | claimed |
| EP-3851447-B1 | METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID | BELLUS HEALTH INC (CA) | 2023-09-06 | — | — | EP | claimed |
| EP-3851447-A1 | METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID | BHI Limited Partnership (CA) | 2021-07-21 | — | — | EP | claimed |
| CN-102241674-B | Synthesis method and antitumor activity evaluation of 1,1-dimethyl-beta-carboline-3-formacyl amino acid benzyl ester | UNIV CAPITAL MEDICAL | 2012-09-12 | — | — | CN | claimed |
| CN-102250202-A | 1-paranitrophenyl-beta-carboline-3-formyl amine acid carbamates and synthesis method and use thereof | UNIV CAPITAL MEDICAL | 2011-11-23 | — | — | CN | claimed |
| CN-102241674-A | Synthesis method and antitumor activity evaluation of 1,1-dimethyl-beta-carboline-3-formacyl amino acid benzyl ester | UNIV CAPITAL MEDICAL | 2011-11-16 | — | — | CN | claimed |
| CN-101497615-B | Substituted purine, preparation and use in medicine | ZHEJIANG MED XINCHANG PHARM | 2010-12-15 | — | — | CN | claimed |
| CN-101906102-A | Beta-carboline alkaloid derivative, preparation method and application thereof | UNIV CAPITAL MEDICAL | 2010-12-08 | — | — | CN | claimed |
| CN-101597289-A | 2-tryptophyl-beta-tetrahydro carboline-3-formyol amino-acid benzyl ester and its production and application | UNIV CAPITAL MEDICAL (CN) | 2009-12-09 | — | — | CN | claimed |
| CN-101597290-A | β-Ka Lin-3-formyl tryptophyl amino-acid benzyl ester and its production and application | UNIV CAPITAL MEDICAL (CN) | 2009-12-09 | — | — | CN | claimed |
| CN-101497615-A | Substituted purine, preparation and use in medicine | XINCHANG PHARMACEUTICAL FACTORY ZHEJIANG MEDICINE CO LTD (CN) | 2009-08-05 | — | — | CN | claimed |
| US-20080146642-A1 | Propanesulfonic acid amino acid prodrugs that can deliver 3-amino-1-propanesulfonic acid (3APS) by minimizing metabolism associated with that drug, particularly compounds that block or protect amino group of 3APS such that it avoids metabolism by transaminases or monoamine oxidase; Alzheimer's disease | BELLUS HEALTH INC. (CA) | 2008-06-19 | — | — | US | claimed |
| CN-119751538-A | Medicine for removing fat or fat pad and application | 西安莱格瑞生物科技有限公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-117815245-A | Medicine for removing fat or fat pad and application | 西安莱格瑞生物科技有限公司 | 2024-04-05 | — | — | CN | disclosed |
| US-20240065990-A1 | METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID | BELLUS HEALTH INC (CA) | 2024-02-29 | — | — | US | disclosed |
| EP-4289820-A2 | COMPOUNDS FOR USE IN TREATING ALZHEIMER'S DISEASE IN APOE4+/+ PATIENTS | Alzheon, Inc. (US) | 2023-12-13 | — | — | EP | disclosed |
| EP-0514359-B1 | Alkanoyl L-carnitine amides with aminoacids and pharmaceutical compositions containing same, for promoting regeneration of the nervous tissue, inhibiting neuronal degeneration, enhancing the processes of learning and memory, and for the treatment of coma | SIGMA TAU IND FARMACEUTI (IT) | 1995-09-13 | — | — | EP | disclosed |
| US-5270472-A | Alkanoyl L-carnitine amides with aminoacids and pharmaceutical compositions containing same for promoting regeneration of the nervous tissue, inhibiting neuronal degeneration, enhancing the process of learning and memory and for the treatment of coma | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 1993-12-14 | — | — | US | disclosed |
| EP-0514359-A2 | Alkanoyl L-carnitine amides with aminoacids and pharmaceutical compositions containing same, for promoting regeneration of the nervous tissue, inhibiting neuronal degeneration, enhancing the processes of learning and memory, and for the treatment of coma | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1992-11-19 | — | — | EP | disclosed |
| US-4053588-A | PYROGLUTAMIC ACID AMIDES | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240065990-A1 | METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID | APP, PSEN1, PSEN2 | LTA4H 982/4885ALDH1A1 888/4885KMT2A 3091/4885 |
| US-20080146642-A1 | Propanesulfonic acid amino acid prodrugs that can deliver 3-amino-1-propanesulfonic acid (3APS) by minimizing metabolism associated with that drug, particularly compounds that block or protect amino group of 3APS such that it avoids metabolism by transaminases or monoamine oxidase; Alzheimer's disease | DNPEP, DAO, APP | LTA4H 1290/4885ALDH1A1 103/4885KMT2A 2014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.